WASHINGTON, D.C. — In a decisive move to combat the rising tide of maternal mortality in the United States, the Association of Women’s Health, Obstetric and Neonatal Nurses (AWHONN) announced on July 14, 2026, that it has been awarded a $500,000 grant from Merck for Mothers. This significant financial infusion is earmarked for the development and nationwide implementation of the POST-BIRTH Triage Index (PBTI), a first-of-its-kind standardized tool designed to equip emergency departments, urgent care centers, and freestanding emergency facilities with the specialized protocols needed to save postpartum lives.
n
The initiative arrives at a critical juncture for American healthcare. As the nation continues to grapple with maternal health outcomes that lag behind other developed countries, the PBTI represents a systemic shift toward protecting women during the "Fourth Trimester"—the often-overlooked year following childbirth.
n
Main Facts: A New Standard for Postpartum Survival
n
The $500,000 grant from Merck for Mothers—known as MSD for Mothers outside the U.S. and Canada—is specifically targeted at closing a lethal gap in the continuum of care. While obstetric units are highly specialized in managing birth-related complications, the majority of women who experience life-threatening issues after discharge do not return to the labor and delivery ward. Instead, they seek help at general emergency departments (EDs) or urgent care centers.
n
The POST-BIRTH Triage Index (PBTI)
n
The centerpiece of this grant is the development of the PBTI. Unlike general triage tools, which may prioritize patients based on broad symptoms like chest pain or fever, the PBTI is a validated, postpartum-specific algorithm. It is designed to help non-obstetric clinicians—who may not have seen a postpartum patient in weeks or months—quickly identify the "red flags" of late-onset complications such as postpartum hemorrhage, eclampsia, and pulmonary embolism.
n
Targeted Clinical Settings
n
The grant focuses on three primary environments:
n
- n
- Hospital Emergency Departments: The first stop for most acute medical crises.
- Urgent Care Centers: Increasingly used for secondary complications like infections or high blood pressure.
- Freestanding Emergency Departments: Rapidly expanding facilities that often lack immediate access to on-site obstetric consultants.
n
n
n
n
By standardizing care across these diverse settings, AWHONN aims to ensure that a woman’s zip code or choice of facility does not determine her chance of surviving a postpartum complication.
n
Chronology: From Warning Signs to Systemic Solutions
n
The journey toward the PBTI began years ago with AWHONN’s recognition that patient education alone was not enough to solve the maternal mortality crisis.
n
The PBWS Foundation
n
The PBTI is the logical evolution of AWHONN’s highly successful POST-BIRTH Warning Signs (PBWS) program. Launched to empower patients, the PBWS program currently reaches over 1.7 million postpartum individuals annually. It provides discharge education that teaches parents how to recognize symptoms like "Post-birth" (Pain in chest, Obstructed breathing, Seizures, Thoughts of hurting yourself, Bleeding, Incision that is not healing, Red or swollen leg, Temperature of 100.4 or higher, Headache that does not go away).
n
Identifying the "Hand-Off" Failure
n
While the PBWS program successfully taught women when to seek help, research soon revealed a secondary problem: when these women arrived at the emergency room, the system was not always ready for them. A 2024-2025 multi-state study involving 23 emergency departments across 17 states identified a "diagnostic blind spot." Clinicians in non-obstetric settings often failed to ask if a patient had recently given birth, leading to misdiagnosis or delayed treatment of pregnancy-related conditions.
n
2026: The Implementation Phase
n
With the funding secured in July 2026, AWHONN has laid out a rigorous roadmap for the next 24 months:
n
- n
- Establishment of a Multidisciplinary Expert Panel: Bringing together ER physicians, obstetricians, nurses, and patient advocates to refine the index.
- Three-Phase Research Study: Validating the tool’s efficacy in diverse clinical environments to ensure it reduces "time to treatment."
- Protocol Expansion: Developing the digital and physical infrastructure to integrate PBTI into Electronic Health Records (EHRs) nationwide.
n
n
n
n
Supporting Data: The Lethal Reality of the Postpartum Period
n
The necessity of this grant is underscored by harrowing statistics provided by the Centers for Disease Control and Prevention (CDC) and maternal mortality review committees.
n
The Danger Zone
Research indicates that more than 50% of pregnancy-related deaths occur between seven and 365 days after delivery. This "late postpartum" period is when women are most likely to be disconnected from their obstetric providers and most likely to present at a general ED.
Preventability
Perhaps the most striking data point is that the CDC estimates over 80% of these postpartum deaths are preventable. The primary barriers to prevention are:
- Delayed Recognition: Symptoms like headaches or shortness of breath being dismissed as "new parent exhaustion" rather than signs of preeclampsia or cardiomyopathy.
- Lack of Specialized Training: Only a small fraction of ER nurses receive mandatory, recurring training on postpartum emergencies.
- Systemic Fragmentation: A lack of standardized communication between emergency medicine and obstetrics.
The PBTI aims to tackle these barriers head-on by providing a "cheat sheet" for survival that triggers immediate, life-saving protocols the moment a patient is identified as being within one year of childbirth.
Official Responses: A Partnership for Change
Leaders from both AWHONN and Merck for Mothers have emphasized that this grant is not just a financial transaction, but a strategic partnership aimed at systemic overhaul.
Perspective from AWHONN
Jonathan Webb, MBA, MPH, the CEO of AWHONN, highlighted the vulnerability of the postpartum stage. "This investment represents a significant step forward in improving maternal safety during one of the most vulnerable periods in a woman’s healthcare journey," Webb stated. "By developing the first validated postpartum-specific triage index for emergency and urgent care settings, we can help clinicians identify life-threatening complications more quickly, improve care coordination and ultimately save lives."
Webb’s comments reflect a growing movement within the nursing profession to expand the scope of maternal health advocacy beyond the delivery room and into the broader community health infrastructure.
Perspective from Merck for Mothers
Jacquelyn Caglia, Head of Merck for Mothers, reinforced the organization’s commitment to global maternal health equity. "Merck for Mothers believes that every mother deserves access to high-quality, timely care throughout the postpartum period," said Caglia. "We are honored to support AWHONN’s efforts to expand this important work, building on the success of the Post-Birth Warning Signs program and helping to strengthen systems providing care for families across the United States during this critical time."
Implications: Reshaping the Future of Maternal Health
The implications of the PBTI extend far beyond the walls of the emergency room. This initiative has the potential to reshape the standard of care on several levels.
Closing the Health Equity Gap
Maternal mortality disproportionately affects Black and Indigenous women, who are three to four times more likely to die from pregnancy-related causes than white women. By standardizing triage through an evidence-based index, the PBTI helps remove "clinical intuition"—which can be subject to implicit bias—from the equation. When every patient is screened using the same rigorous tool, the likelihood of a minority patient’s symptoms being dismissed is significantly reduced.
Interdisciplinary Integration
The PBTI forces a reconciliation between two historically siloed fields: Emergency Medicine and Obstetrics. As this tool becomes a standard in EDs, it will necessitate better communication channels, such as "warm hand-offs" and shared electronic records, ensuring that a woman’s obstetric history follows her into every medical encounter.
Economic Impact
Maternal mortality and morbidity carry a heavy economic burden, estimated in the billions due to medical costs, loss of workforce productivity, and the long-term social costs associated with the loss of a primary caregiver. By preventing acute crises from becoming fatal, the PBTI offers a high return on investment for the public health system.
Empowering the Nursing Workforce
As an organization of nurses, AWHONN is uniquely positioned to lead this change. Nurses are the primary users of triage systems. Providing them with a validated tool like the PBTI empowers them to advocate for their patients, giving them the objective data needed to escalate care to physicians and specialists.
Conclusion: A Vision for a Safer "Fourth Trimester"
The $500,000 grant from Merck for Mothers to AWHONN is more than an award; it is a catalyst for a safer America for mothers. As implementation begins in 2026, the healthcare industry will be watching closely. The transition from the POST-BIRTH Warning Signs (PBWS) to the POST-BIRTH Triage Index (PBTI) marks the completion of a circle of care—one that starts with an educated patient and ends with a prepared, responsive healthcare system.
Through research, education, and standardized clinical protocols, AWHONN and Merck for Mothers are building a future where the joy of a new birth is not overshadowed by the preventable tragedy of maternal loss. As Jonathan Webb noted, the ultimate goal is simple yet profound: to ensure that every mother who enters an emergency room leaves it to return home to her family.
About AWHONN
The Association of Women’s Health, Obstetric and Neonatal Nurses (AWHONN) is a 501(c)3 nonprofit membership organization. Our mission is to empower and support nurses caring for women, newborns, and their families through research, education, and advocacy.
About Merck for Mothers
Merck for Mothers is Merck’s global initiative to help create a world where no woman has to die while giving life. Using Merck’s business and scientific expertise, the initiative works to improve the quality of maternal care and modernize postpartum support.
